References
- Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177–189.10.1212/WNL.0000000000001729
- Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485–1489.10.1212/01.wnl.0000216139.44259.74
- Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–2112.10.1016/S0140-6736(04)17551-X
- Ito S, Mori M, Makino T, Hayakawa S, et al. “Cloud-like enhancement” is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol. 2009;66:425–428.
- Gao C, Wu L, Chen X, et al. Hypothalamic abnormality in patients with inflammatory demyelinating disorders. Int J Neurosci. 2015;29:1–28.
- Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006;63:390–396.10.1001/archneur.63.3.390
- Pittock SJ, Weinshenker BG, Lucchinetti CF, et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006;63:964–968.10.1001/archneur.63.7.964
- Kim W, Park MS, Lee SH, et al. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler. 2010;16:1229–1236.10.1177/1352458510376640
- Kim HJ, Paul F, Lana-Peixoto MA, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015;84:1165–1173.10.1212/WNL.0000000000001367
- Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.10.1002/ana.22366
- Long Y, Qiu W, Lu Z, et al. Aquaporin 4 antibodies in the cerebrospinal fluid are helpful in diagnosing chinese patients with neuromyelitis optica. Neuroimmunomodulation. 2012;19:96–102.10.1159/000330240
- Pisani F, Sparaneo A, Tortorella C, et al. Aquaporin-4 autoantibodies in neuromyelitis optica: aqp4 isoform-dependent sensitivity and specificity. PLoS ONE. 2013;8:e79185.10.1371/journal.pone.0079185
- Xie L, Long Y, Yang N, et al. No overlap among serum GAD65, NMDAR and AQP4 antibodies in patients with neuromyelitis optica spectrum disorders. Neuroimmunomodulation. 2015;22:337–341.10.1159/000371492
- Kim W, Kim SH, Huh SY, et al. Brain abnormalities in neuromyelitis optica spectrum disorder. Mult Scler Int. 2012;2012:735486.
- Titulaer MJ, Hoftberger R, Iizuka T, et al. Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014;75:411–428.10.1002/ana.24117